Septic shock is a form of distributive shock characterized by widespread vasodilation due to inflammatory mediators. This leads to a profound decrease in systemic vascular resistance (SVR), causing hypotension. In the early 'warm shock' phase, the heart compensates for the low SVR by increasing heart rate and stroke volume, resulting in a high or normal cardiac output. This contrasts with cardiogenic shock, which is defined by a primary pump failure leading to low cardiac output and a compensatory, reflexive increase in SVR (causing cool, clammy skin).

This patient's presentation is classic for stable angina, which is characterized by exertional chest pain due to a mismatch between myocardial oxygen supply and demand, relieved by rest. The underlying pathology is a stable atherosclerotic plaque with a thick, intact fibrous cap that narrows the coronary lumen but does not rupture. This fixed obstruction limits blood flow during times of increased demand. Plaque rupture with thrombosis is characteristic of acute coronary syndromes like unstable angina or myocardial infarction. Vasospasm is the mechanism of Prinzmetal angina. Plaque erosion is another cause of acute coronary syndrome.

Myocardial stunning refers to the temporary loss of contractile function in myocardial tissue that persists for hours to days after reperfusion, even though the tissue is viable. It is thought to be caused by oxidative stress, calcium overload, and inflammation associated with reperfusion. Myocardial hibernation is a state of chronic, but reversible, contractile dysfunction in response to chronic ischemia. Ventricular remodeling is a long-term process of changes in ventricular size, shape, and function after an MI. The no-reflow phenomenon is a failure to perfuse the microvasculature despite an open epicardial artery.

In systolic heart failure, decreased cardiac output leads to reduced renal perfusion, which activates the renin-angiotensin-aldosterone system (RAAS). Angiotensin II causes vasoconstriction and stimulates aldosterone release. Aldosterone acts on the renal distal tubules and collecting ducts to increase sodium and water reabsorption, leading to volume expansion, which is initially compensatory but becomes maladaptive, causing systemic and pulmonary congestion. Natriuretic peptides (ANP, BNP) are released in response to stretch and promote vasodilation and natriuresis, counteracting RAAS, but their effects are often overwhelmed in advanced heart failure.

This patient has heart failure with preserved ejection fraction (HFpEF), also known as diastolic heart failure. The primary mechanism is impaired diastolic function. Long-standing hypertension causes pressure overload, leading to concentric hypertrophy. This hypertrophied ventricle is stiff and relaxes poorly during diastole, impairing ventricular filling and leading to elevated left ventricular end-diastolic pressure. This pressure is transmitted backward to the left atrium and pulmonary circulation, causing pulmonary congestion and dyspnea. Systolic function (contractility) is preserved, as indicated by the normal ejection fraction.

This patient's presentation is highly suggestive of viral myocarditis leading to dilated cardiomyopathy (DCM). The primary pathophysiologic defect in DCM is impaired myocardial contractility (systolic dysfunction). The viral infection and subsequent immune response damage myocytes, leading to a dilated, thin-walled, and poorly contracting ventricle. This results in a reduced ejection fraction and symptoms of systolic heart failure. While diastolic dysfunction can also be present, the defining feature is the profound impairment of systolic function.

This patient has aortic regurgitation (AR). The wide pulse pressure (systolic minus diastolic pressure) is a hallmark of chronic AR. The left ventricle ejects a large stroke volume (forward flow plus regurgitant volume from the previous beat) into the aorta, causing a high systolic pressure. During diastole, blood flows backward from the aorta into the left ventricle through the incompetent aortic valve. This regurgitant flow, or 'diastolic runoff,' causes a rapid decline in aortic pressure, leading to a very low diastolic pressure and thus a wide pulse pressure.

A large VSD initially causes a left-to-right shunt, leading to excessive blood flow through the pulmonary circulation. Over time, this chronic volume and pressure overload causes medial hypertrophy and intimal proliferation of the pulmonary arterioles, a process known as pulmonary vascular obstructive disease. This leads to a progressive increase in pulmonary vascular resistance and pulmonary artery pressure. Eventually, the pressure in the right ventricle exceeds the pressure in the left ventricle, causing the shunt to reverse (right-to-left). This reversal, known as Eisenmenger syndrome, results in deoxygenated blood entering the systemic circulation, causing cyanosis.

A hypercyanotic or 'tet' spell in Tetralogy of Fallot is caused by an acute increase in the right-to-left shunt. The primary trigger is often a sudden decrease in systemic vascular resistance (SVR) or an increase in right ventricular outflow tract (RVOT) obstruction. Dynamic spasm of the hypertrophied infundibular muscle is a key mechanism that acutely worsens the RVOT obstruction. This makes it harder for blood to enter the pulmonary artery, shunting more deoxygenated blood from the right ventricle across the VSD into the aorta, leading to profound cyanosis. Squatting increases SVR, which helps to reverse the shunt and improve oxygenation.

This clinical presentation is classic for atrioventricular nodal reentrant tachycardia (AVNRT), the most common type of paroxysmal supraventricular tachycardia (PSVT). The underlying mechanism is the presence of dual AV nodal pathways (a fast pathway and a slow pathway) with different conduction velocities and refractory periods. This allows for the formation of a micro-reentrant circuit within the AV node, leading to a rapid, regular tachycardia. Vagal maneuvers, like bearing down (Valsalva), increase parasympathetic tone to the AV node, which can block the circuit and terminate the arrhythmia.